Table 3. Haplotypes and antimicrobial sensitivity phenotypes for S. Typhi isolated from individuals vaccinated with Vi.
| Haplotype | Resistance phenotype | No. isolates |
| H14 | NalR | 1 |
| H37 | S | 1 |
| H42 | S | 1 |
| H42 | NalR | 3 |
| H58-A | NalR | 1 |
| H58-B | S | 11 |
| H58-B | NalR | 3 |
| H58-G | MDR | 1 |
| H58-G | NalR | 7 |
| H58-G | NalR, MDR | 3 |
| H58-H64 | NalR | 1 |
| H58-H64 | NalR, MDR | 1 |
Haplotypes correspond to those defined in Figure 1. NalR: Nalidixic acid resistant (MIC>256 µg/mL); MDR: multidrug resistant, defined as resistant to chloramphenicol (MIC>256 µg/mL), ampicillin (MIC>256 µg/mL) and co-trimoxazole (MIC>32 µg/mL); S: susceptible to all antimicrobials tested.